Prevalence of the Metabolic Syndrome and Associated Factors in Korean Cancer Survivors

Lee, Jung‐Yun; Park, Noh Hyun; Song, Yong Sang; Park, Sang Min; Lee, Hae Won; Kim, Kyae Hyung; Choi, Kyung Hyun

doi:10.7314/apjcp.2013.14.3.1773

Cited by 18 publications

(14 citation statements)

References 56 publications

(66 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The ratio of people in their 40s was low and for age 60 and older was high in the onset and persistent metabolic syndrome groups than the no metabolic syndrome group. This is consistent with a previous study that increased age of cancer survivors increases the risk of metabolic syndrome [ 22 ]. Furthermore, the percentage of menopausal subjects in the onset and persistent metabolic syndrome groups were found to be high, with that of continuing metabolic syndrome group being particularly high at 95.8%.…”

Section: Discussionsupporting

confidence: 94%

Factors Affecting Onset and Persistence of Metabolic Syndrome in Korean Breast Cancer Survivors: A Prospective Study

Maeng

2020

IJERPH

View full text Add to dashboard Cite

This study aimed to investigate the onset and persistence of metabolic syndrome in breast cancer survivors in a community setting. The study included 329 female breast cancer survivors from 39 community health examination centers located in 14 urban areas in Korea. After an average of 4.6 years of follow-up, based on the presence of metabolic syndrome at baseline and follow-up, the subjects were assigned to three groups: Non-metabolic syndrome (n = 249), onset (n = 32), and persistent (n = 48). Factors associated with the metabolic syndrome were analyzed and presented as odds ratios (ORs). Older age, postmenopausal status, lower education, and lower-income level were associated with an increased prevalence of metabolic syndrome in the onset Mets and persistent Mets group. In particular, when the breast cancer survivor was obese (≥25 kg/m2), the probability of developing metabolic syndrome was 3.33 times higher than normal-weight subjects (<23 kg/m2) and the probability of metabolic syndrome persisting was 16.34 times. When breast cancer survivors were in their 60s or older, the probability of metabolic syndrome persisting was 4.27 times higher than those in their 40s. To prevent the onset and persistence of metabolic syndrome in breast cancer survivors, health-care providers should identify risk factors. Obesity, in particular, should be controlled.

show abstract

Section: Discussionsupporting

confidence: 94%

Factors Affecting Onset and Persistence of Metabolic Syndrome in Korean Breast Cancer Survivors: A Prospective Study

Maeng

2020

IJERPH

View full text Add to dashboard Cite

show abstract

“…This difference can be attributed to the variation in breast cancer survival duration and ethnic composition percentage among the breast cancer survivors between these two studies. Furthermore, MetS prevalence among breast cancer survivors as reported in the current study was also similar, or higher than the data reported in other countries such as India – NCEP ATP III definition: 40.0% vs 40.0% [ 8 ], China – Harmonized definition: 50.5% vs 32.6% [ 9 ], Korea – Harmonized definition: 50.5% vs 43.9% [ 10 ], USA – Harmonized definition: 50.5% vs 26.1% [ 11 ], Denmark – NCEP ATP III definition: 40.0% vs 15.1% [ 13 ] and Brazil – Harmonized definition: 50.5% vs 48.1% [ 12 ] respectively.…”

Section: Discussionsupporting

confidence: 85%

“…In Malaysia, the prevalence of MetS among breast cancer patients was reported at 37.8% [ 6 ]. In other Asian and Western countries, MetS prevalence among breast cancer survivors were reported at comparable magnitude in countries such as India (31.1 to 40.0%) [ 7 , 8 ], China (32.9%) [ 9 ], Korea (43.9%) [ 10 ], USA (26.1%) [ 11 ], and Brazil 48.1% [ 12 ]. Prevalence of MetS among breast cancer patients in Denmark was rather lower (15.1%) than other reported studies [ 13 ].…”

Section: Introductionmentioning

confidence: 99%

Prevalence of metabolic syndrome among breast cancer survivors in East Coast of Peninsular Malaysia

et al. 2021

View full text Add to dashboard Cite

Background To date, limited data are available on metabolic syndrome prevalence among breast cancer survivors in Malaysia. Therefore, this study was conducted to determine the prevalence of metabolic syndrome and abnormal metabolic syndrome components among breast cancer survivors in East Coast of Peninsular Malaysia. Methods This cross-sectional study included 95 breast cancer survivors (age 53.7 ± 7.6 years) who have completed main cancer treatments for ≥6 months. Cancer survivors were recruited from two main government hospitals in Kelantan and Terengganu using a purposive sampling method. Results According to the Harmonized criteria, the metabolic syndrome prevalence was 50.5%. Among those with metabolic syndrome, the most prevalent abnormal metabolic components were triglycerides (91.2%), fasting blood glucose (79.6%) and HDL-c level (78.4%). Except for total cholesterol and LDL-c, all other metabolic syndrome components were significantly different (p < 0.05) between those with and without metabolic syndrome. Significant differences between metabolic syndrome and non-metabolic syndrome groups were found for weight, BMI, waist circumference, body fat percentage and cancer stages (p < 0.05). However, no significant relationship was reported between sociodemographic, clinical parameters and metabolic syndrome among breast cancer survivors in this study. Conclusions Metabolic syndrome was highly prevalent among breast cancer survivors. It is recommended for health care professionals to closely monitor and improve the triglycerides, blood glucose and HDL-c level of the breast cancer survivors under their care to control the detrimental effect of metabolic syndrome.

show abstract

“…reported a 37.8% prevalence of MetS among breast cancer patients [6]. In comparison to MetS prevalence among breast cancer survivors in other Asian countries, the prevalence of MetS in India were reported to range between 32.1% [7] and 40.0% [8], whereas MetS prevalence in China and Korea were 32.6% [9] and 43.9% [10] respectively. Meanwhile, studies conducted in the USA, Denmark and Brazil reported MetS prevalence among breast cancer survivors to be 26.1% [11], 15.1% [12], and 48.1% [13] respectively.…”

Section: Introductionmentioning

confidence: 99%

Prevalence of Metabolic Syndrome among Breast Cancer Survivors in East Coast of Peninsular Malaysia

Shahril

Amirfaiz

Lua

et al. 2020

Preprint

View full text Add to dashboard Cite

To date, limited data are available on metabolic syndrome prevalence among breast cancer survivors in Malaysia. Therefore, this study was conducted to determine the prevalence of metabolic syndrome and abnormal metabolic syndrome components among breast cancer survivors in East Coast of Peninsular Malaysia. This cross-sectional study included 95 breast cancer survivors (age 53.7±7.6 years) who have completed main cancer treatments for ≥6 months. Cancer survivors were recruited from two main government hospitals in Kelantan and Terengganu using a purposive sampling method. According to the Harmonized criteria, the metabolic syndrome prevalence was 50.5%. Among those with metabolic syndrome, the most prevalent abnormal metabolic components were triglycerides (91.2%), fasting blood glucose (79.6%) and HDL-c level (78.4%). Except for total cholesterol and LDL-c, all other metabolic syndrome components were significantly different (p<0.05) between those with and without metabolic syndrome. Significant differences between metabolic syndrome and non-metabolic syndrome groups were found for weight, BMI, waist circumference, body fat percentage and cancer stages (p<0.05). However, no significant relationship was reported between sociodemographic, clinical parameters and metabolic syndrome among breast cancer survivors in this study. In conclusion, metabolic syndrome was highly prevalent among breast cancer survivors. It is recommended for health care professionals to closely monitor and improve the triglycerides, blood glucose and HDL-c level of the breast cancer survivors under their care to control the detrimental effect of metabolic syndrome.

show abstract

Prevalence of the Metabolic Syndrome and Associated Factors in Korean Cancer Survivors

Cited by 18 publications

References 56 publications

Factors Affecting Onset and Persistence of Metabolic Syndrome in Korean Breast Cancer Survivors: A Prospective Study

Factors Affecting Onset and Persistence of Metabolic Syndrome in Korean Breast Cancer Survivors: A Prospective Study

Prevalence of metabolic syndrome among breast cancer survivors in East Coast of Peninsular Malaysia

Prevalence of Metabolic Syndrome among Breast Cancer Survivors in East Coast of Peninsular Malaysia

Contact Info

Product

Resources

About